Archive - Latest News Search Engine - Global and Local Breaking News

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

Golden Helix Partners with the Danish Healthcare Regions to Drive Advancements in Genomic Medicine

Golden Helix Partners with the Danish Healthcare Regions to Drive Advancements in Genomic Medicine

Roshni Nadar Malhotra to become third richest Indian after dad Shiv Nadar gifts HCL stake

Roshni Nadar Malhotra to become third richest Indian after dad Shiv Nadar gifts HCL stake

Your briefing

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Building on last year's momentum of 18 FDA 510(k) Clearances and 45 global product launches, the company accelerates innovation across joint reconstru...

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patien...

Topline results also show investigational targeted oral peptide icotrokinra achieved clinical remission rates up to 30.2% at Week 12 and a favorable s...

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

Golden Helix Partners with the Danish Healthcare Regions to Drive Advancements in Genomic Medicine

BOZEMAN, Mont., March 10, 2025 /PRNewswire/ -- Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and prec...

Golden Helix Partners with the Danish Healthcare Regions to Drive Advancements in Genomic Medicine

Roshni Nadar Malhotra to become third richest Indian after dad Shiv Nadar gifts HCL stake

Roshni Nadar Malhotra becomes India's third-richest individual after receiving a 47% stake in HCL Corporation and Vama Delhi from her father, Shiv Nad...

Roshni Nadar Malhotra to become third richest Indian after dad Shiv Nadar gifts HCL stake